We are live on ! Find out more
OAM

Oppenheimer Asset Management Portfolio holdings

AUM $9.63B
1-Year Est. Return 30.32%
This Fund
S&P 500
This Quarter Est. Return
-4.92%
1 Year Est. Return
+30.32%
3 Year Est. Return
+85%
5 Year Est. Return
+99.62%
10 Year Est. Return
+601.29%
AUM
$5.67B
AUM Growth
-$299M
Cap. Flow
+$87M
Cap. Flow %
1.54%
Top 10 Hldgs %
15.69%
Holding
1,191
New
34
Increased
560
Reduced
521
Closed
72

Sector Composition

Rank Sector Weight
1 Technology 18.39%
2 Healthcare 14.24%
3 Financials 13.38%
4 Consumer Discretionary 10.55%
5 Industrials 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LILAK icon
1001
Liberty Latin America Class C
LILAK
$1.64B
$245K ﹤0.01%
43,896
-707
-2% -$4.55K
LRCX icon
1002
Lam Research
LRCX
$390B
$245K ﹤0.01%
6,700
-5,220
-44% -$232K
OC icon
1003
Owens Corning
OC
$12.4B
$243K ﹤0.01%
3,088
+64
+2% +$5.38K
MKTX icon
1004
MarketAxess Holdings
MKTX
$5.72B
$242K ﹤0.01%
1,090
-30
-3% -$7.7K
TIPT icon
1005
Tiptree Inc
TIPT
$675M
$242K ﹤0.01%
22,503
-541
-2% -$6.17K
APAM icon
1006
Artisan Partners
APAM
$3.02B
$241K ﹤0.01%
8,963
+3
+0% +$105
CASY icon
1007
Casey's General Stores
CASY
$30.9B
$240K ﹤0.01%
+1,187
New +$246K
AVY icon
1008
Avery Dennison
AVY
$13.4B
$239K ﹤0.01%
1,473
-575
-28% -$104K
EYE icon
1009
National Vision
EYE
$1.81B
$237K ﹤0.01%
7,264
-536
-7% -$17.4K
SWTX
1010
DELISTED
SpringWorks Therapeutics
SWTX
$237K ﹤0.01%
8,310
-372
-4% -$10.7K
HBAN icon
1011
Huntington Bancshares
HBAN
$35.5B
$233K ﹤0.01%
17,651
+4,638
+36% +$62K
PHR icon
1012
Phreesia
PHR
$773M
$233K ﹤0.01%
9,158
-571
-6% -$14.3K
CX icon
1013
Cemex
CX
$16.3B
$232K ﹤0.01%
67,506
+1,525
+2% +$6.03K
RSSS icon
1014
Research Solutions
RSSS
$72.2M
$229K ﹤0.01%
112,280
-1,603
-1% -$2.99K
WRBY icon
1015
Warby Parker
WRBY
$3.27B
$229K ﹤0.01%
17,140
-1,622
-9% -$21.6K
AXS icon
1016
AXIS Capital
AXS
$7.55B
$228K ﹤0.01%
+4,637
New +$246K
CCSI icon
1017
Consensus Cloud Solutions
CCSI
$647M
$227K ﹤0.01%
4,807
-41
-0.8% -$2.11K
FHB icon
1018
First Hawaiian
FHB
$3.35B
$227K ﹤0.01%
9,221
+252
+3% +$6.35K
SCHX icon
1019
Schwab US Large- Cap ETF
SCHX
$74.6B
$227K ﹤0.01%
+16,050
New +$252K
ACAD icon
1020
Acadia Pharmaceuticals
ACAD
$5.03B
$225K ﹤0.01%
13,735
-862
-6% -$14K
EA
1021
DELISTED
Electronic Arts
EA
$225K ﹤0.01%
+1,944
New +$246K
PRI icon
1022
Primerica
PRI
$9.89B
$225K ﹤0.01%
1,821
-1
-0.1% -$127
CCF
1023
DELISTED
Chase Corporation
CCF
$224K ﹤0.01%
2,685
-52
-2% -$4.59K
MAXR
1024
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$224K ﹤0.01%
11,940
+316
+3% +$7.75K
INFU icon
1025
InfuSystem Holdings
INFU
$249M
$223K ﹤0.01%
+31,833
New +$267K

Similar funds

Oppenheimer Asset Management's Q3 2022 Portfolio in Review

As of Q3 2022, Oppenheimer Asset Management held 1,191 positions worth $5.67B, down 5% from $5.97B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Oppenheimer Asset Management's Q3 2022 filing shows 34 new, 560 increased, 521 reduced and 72 closed positions. Its largest new stake was State Street Communication Services Select Sector SPDR ETF: 112,462 shares worth $5.39M. The largest sale was Avalara, Inc., an estimated $8.84M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

  • Oppenheimer Asset Management's largest Q3 2022 buy was State Street Communication Services Select Sector SPDR ETF: 112,462 shares worth $5.39M.
  • Oppenheimer Asset Management added most to FedEx in Q3 2022, an estimated $16.9M increase.
  • Oppenheimer Asset Management's biggest Q3 2022 reduction was Avalara, Inc., cutting an estimated $8.84M.
  • Oppenheimer Asset Management fully exited Walgreens Boots Alliance in Q3 2022, selling an estimated $8.36M.
  • Oppenheimer Asset Management's ten largest holdings make up 16% of its $5.67B portfolio in Q3 2022.
  • Oppenheimer Asset Management opened 34 new positions and closed 72 in Q3 2022.
  • Oppenheimer Asset Management's portfolio value fell 5% quarter-over-quarter to $5.67B.

Based on Oppenheimer Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.